GlassScriptPhysician profile
Clinton S Bell
NPI 1891752481
$260,889.70
in general payments reported to CMS, 2019-2025
18 companies · $421 in 2025
The $421 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101K · 2020: $50K · 2021: $38K · 2022: $38K · 2023: $13K · 2024: $21K · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,500.00 |
| Food and Beverage | $1,276.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $209,064.21 | 2019-2024 | |
| Cpm Medical Consultants, LLC | $50,020.76 | 2019-2024 | |
| Corentec America INC | $835.60 | 2024-2025 | |
| Stryker Corporation | $341.13 | 2019-2024 | Hydroset, Variax |
| Ortho Development Corporation | $159.44 | 2022 | |
| Pylant Medical | $73.71 | 2020-2024 | |
| Ferring Pharmaceuticals INC. | $65.36 | 2019-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $61.13 | 2020-2025 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $57.31 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $53.06 | 2019-2023 | Zilretta |
| Molnlycke Health Care US, LLC | $29.84 | 2022 | |
| Convatec INC. | $23.47 | 2023 | |
| Sanofi-Aventis U.S. LLC | $21.28 | 2019 | |
| Bioventus LLC | $18.45 | 2019 | |
| Horizon Therapeutics Plc | $18.34 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $17.65 | 2019 | |
| Pfizer INC. | $14.93 | 2020 | |
| Ermi LLC | $14.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.